Maravai Lifesciences Holdings, Inc. Class A MRVI 深 沪
已收盘 04-02 16:00:00 美东时间
2.95
+0.080
+2.79%
华盛通- 最 高2.98
- 今 开2.82
- 成交量 175.16万股
- 最 低 2.80
- 昨 收 2.87
- 总市值 7.58亿
- 52周最高 4.105
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 1.665
- 委 比 -77.69%
- 总股本 2.57亿
- 历史最高 63.55
- 量 比 1.03
- 振 幅 6.27%
- 历史最低 1.665
- 每 手 1
- 风险率 0.60%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Philips proposes new appointment and re-appointments to its Supervisory Board and CEO re-appointment
Royal Philips has announced proposed appointments and re-appointments to its Supervisory Board. John DeFord, an industry leader with extensive experience in medical devices, has been nominated as a new member. Paul Stoffels, Herna Verhagen, and Sanjay Poonen have been proposed for re-appointment due to their ongoing contributions and expertise. Marc Harrison will step down after completing his second term. Additionally, Roy Jakobs has been re-pro...
03-23 08:30
Maravai Lifesciences Charts Early Turnaround in 2025
Maravai Lifesciences Holdings, Inc. (($MRVI)) has held its Q4 earnings call. Re...
03-01 08:26
Maravai LifeSciences Holdings shares are trading higher after the company reported better-than-expected Q4 financial results and issued FY26 sales guidance with its midpoint above estimates.
Maravai LifeSciences Holdings shares are trading higher after the company repor...
02-26 06:02
Maravai LifeSciences Sees FY2026 Sales $200.000M-$210.000M vs $203.430M Est
Maravai LifeSciences (NASDAQ:MRVI) sees FY2026 sales of $200.000 million-$210.000 million vs $203.430 million analyst estimate.
02-26 05:08
Maravai LifeSciences Q4 Adj. EPS $(0.04) Beats $(0.07) Estimate, Sales $49.866M Beat $49.047M Estimate
Maravai LifeSciences (NASDAQ:MRVI) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.07) by 43.66 percent. This is a 33.33 percent increase over losses of $(0.06) per share
02-26 05:07
Earnings Scheduled For February 25, 2026
Companies Reporting Before The Bell • Clear Secure (NYSE:YOU) is expected to re...
02-25 19:11
Maravai LifeSciences Holdings Inc. kündigt Veröffentlichung von Finanzergebnissen an
Maravai LifeSciences Holdings Inc. kündigt Veröffentlichung von Finanzergebnissen an Maravai LifeSciences Holdings Inc. wird die Finanz- und Betriebsergebnisse für das vierte Quartal und das Gesamtjahr 2025 am Mittwoch, den 25. Februar 2026, nach Börsenschluss veröffentlichen. Die Ergebnisse werden
02-10 06:05
Maravai LifeSciences Holdings Inc. to Announce Financial and Operating Results and Host Earnings Call
Maravai LifeSciences Holdings Inc. to Announce Financial and Operating Results and Host Earnings Call Maravai LifeSciences Holdings Inc. will announce its fourth quarter and full year 2025 financial and operating results after the market close on Wednesday, February 25, 2026. The results will be rel
02-10 06:05
美股大行评级 | 潜在涨幅113%！麦格理首予小马智行“跑赢大市"评级目标价29美元；Roth Capital下调好市多至"卖出"，目标价从906美元降至769美元
今日重点评级关注：HC Wainwright & Co.：维持BioCryst Pharma"买入"评级，目标价从30美元升至32美元；TD Cowen：上调Milestone Pharmaceuticals评级至"买入"，目标价8美元
2025-12-16 09:36
Wells Fargo Maintains Overweight on Maravai LifeSciences, Raises Price Target to $4.5
Wells Fargo analyst Brandon Couillard maintains Maravai LifeSciences (NASDAQ:MRVI) with a Overweight and raises the price target from $4 to $4.5.
2025-12-16 02:25
